Human decidual cell Toll-like receptor signaling in response to endotoxin: the effect of progestins.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 2712725)

Published in Am J Obstet Gynecol on October 22, 2007

Authors

Hyagriv N Simhan1, Jye-Ping Chiao, Donald R Mattison, Steve N Caritis

Author Affiliations

1: Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Articles cited by this

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med (2003) 9.57

Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol (2003) 6.74

Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology (2004) 4.09

Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science (2005) 3.64

Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol (2006) 3.44

Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA (2001) 1.92

Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab (2002) 1.85

Animal models of preterm birth. Trends Endocrinol Metab (2004) 1.74

Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr Rev (2006) 1.68

The preterm labor syndrome. Ann N Y Acad Sci (1994) 1.66

Roles for accessory molecules in microbial recognition by Toll-like receptors. J Endotoxin Res (2006) 1.59

Apoptosis and its role in the trophoblast. Am J Obstet Gynecol (2006) 1.55

Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol (1990) 1.53

Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States. Obstet Gynecol (2005) 1.38

Multiplicity of progesterone's actions and receptors in the mammalian ovary. Biol Reprod (2006) 1.14

Inflammatory mediators regulate interleukin-8 production by cultured gestational tissues: evidence for a cytokine network at the chorio-decidual interface. J Clin Endocrinol Metab (1993) 0.97

Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation? Am J Obstet Gynecol (2005) 0.97

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro. Reprod Biol Endocrinol (2004) 0.97

Innate immune function of the human decidual cell at the maternal-fetal interface. J Reprod Immunol (2006) 0.91

Pregnancy, progesterone and progestins in relation to breast cancer risk. J Steroid Biochem Mol Biol (2005) 0.86

Regulation of decidual cell and chorion cell production of interleukin-10 by purified bacterial products. Am J Reprod Immunol (1997) 0.85

The effect of the anti-inflammatory cytokines interleukin-4 and interleukin-10 on lipopolysaccharide-stimulated production of prostaglandin E2 by cultured human decidual cells. J Reprod Immunol (2004) 0.84

Effect of tocolytics on interleukin-8 production by human amniotic and decidual cells. J Reprod Immunol (2005) 0.81

Hydroxyprogesterone caproate and progesterone increase tumor necrosis factor-alpha production in lipopolysaccharide stimulated whole blood from non-pregnant women. J Perinat Med (2005) 0.79

Articles by these authors

Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med (2004) 9.62

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med (2003) 9.57

Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med (2009) 6.86

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med (2008) 5.11

Fetal pulse oximetry and cesarean delivery. N Engl J Med (2006) 4.45

Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol (2006) 3.87

Prevention of preterm delivery. N Engl J Med (2007) 3.26

Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol (2006) 3.15

The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol (2011) 2.96

A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis. N Engl J Med (2015) 2.86

Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med (2002) 2.78

The Preterm Prediction Study: association between maternal body mass index and spontaneous and indicated preterm birth. Am J Obstet Gynecol (2005) 2.77

A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med (2007) 2.73

Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol (2006) 2.69

Fetal injury associated with cesarean delivery. Obstet Gynecol (2006) 2.61

Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Am J Obstet Gynecol (2005) 2.51

Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med (2007) 2.30

Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol (2007) 2.19

Environmental exposures and adverse pregnancy outcomes: a review of the science. Reprod Sci (2008) 2.04

The heart of the matter on breastmilk and environmental chemicals: essential points for healthcare providers and new parents. Breastfeed Med (2008) 1.85

Asthma during pregnancy. Obstet Gynecol (2004) 1.79

The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol (2004) 1.75

Prediction of uterine rupture associated with attempted vaginal birth after cesarean delivery. Am J Obstet Gynecol (2008) 1.70

Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol (2006) 1.65

A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract (2012) 1.63

Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use. Int J Pediatr Endocrinol (2009) 1.57

Risk-adjusted models for adverse obstetric outcomes and variation in risk-adjusted outcomes across hospitals. Am J Obstet Gynecol (2013) 1.54

Timing of elective repeat cesarean delivery at term and maternal perioperative outcomes. Obstet Gynecol (2011) 1.54

The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. Am J Obstet Gynecol (2005) 1.54

Maternal obesity, uterine activity, and the risk of spontaneous preterm birth. Obstet Gynecol (2009) 1.49

17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol (2012) 1.49

Ending propylthiouracil-induced liver failure in children. N Engl J Med (2009) 1.40

Comparison of transverse and vertical skin incision for emergency cesarean delivery. Obstet Gynecol (2010) 1.39

Pharmacokinetics of oseltamivir among pregnant and nonpregnant women. Am J Obstet Gynecol (2011) 1.36

Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet (2009) 1.35

Outcomes of induction of labor after one prior cesarean. Obstet Gynecol (2007) 1.34

Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol (2010) 1.34

Sex differences in drug disposition. J Biomed Biotechnol (2011) 1.33

Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Obstet Gynecol (2010) 1.31

Exposure to Hurricane Katrina, post-traumatic stress disorder and birth outcomes. Am J Med Sci (2008) 1.31

Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol (2011) 1.28

Failed operative vaginal delivery. Obstet Gynecol (2009) 1.27

The changing epidemiology of multiple births in the United States. Obstet Gynecol (2003) 1.26

Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery. Am J Obstet Gynecol (2005) 1.25

Comparison of maternal and infant outcomes from primary cesarean delivery during the second compared with first stage of labor. Obstet Gynecol (2007) 1.24

Second-stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. Am J Obstet Gynecol (2009) 1.23

Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. J Child Adolesc Psychopharmacol (2007) 1.22

The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am J Obstet Gynecol (2002) 1.22

Failed labor induction: toward an objective diagnosis. Obstet Gynecol (2011) 1.18

Antioxidants and the prevention of preeclampsia--unresolved issues. N Engl J Med (2006) 1.17

Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol (2003) 1.17

The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol (2004) 1.15

Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet Gynecol (2007) 1.13

The MFMU Cesarean Registry: impact of time of day on cesarean complications. Am J Obstet Gynecol (2006) 1.09

Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol (2003) 1.08

Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol (2003) 1.08

Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes. Am J Perinatol (2010) 1.08

Blood transfusion and cesarean delivery. Obstet Gynecol (2006) 1.08

Clinical therapeutics in pregnancy. J Biomed Biotechnol (2011) 1.08

Hurricane Katrina experience and the risk of post-traumatic stress disorder and depression among pregnant women. Am J Disaster Med (2010) 1.08

Spirometry is related to perinatal outcomes in pregnant women with asthma. Am J Obstet Gynecol (2006) 1.07

Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Am J Obstet Gynecol (2010) 1.07

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics. Br J Clin Pharmacol (2012) 1.07

Maternal and neonatal outcomes of repeat cesarean delivery in women with a prior classical versus low transverse uterine incision. Am J Perinatol (2010) 1.07

Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. Am J Obstet Gynecol (2007) 1.06

Are women with recurrent spontaneous preterm births different from those without such history? Am J Obstet Gynecol (2006) 1.04

Menstrual bleeding patterns among regularly menstruating women. Am J Epidemiol (2012) 1.02

The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol (2005) 1.02

Can a prediction model for vaginal birth after cesarean also predict the probability of morbidity related to a trial of labor? Am J Obstet Gynecol (2008) 1.02

Bisphenol A and indicators of obesity, glucose metabolism/type 2 diabetes and cardiovascular disease: a systematic review of epidemiologic research. Crit Rev Toxicol (2014) 1.02

Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. Biochem Pharmacol (2009) 1.02

Transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol (2008) 1.01

Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol (2007) 1.00

The frequency and complication rates of hysterectomy accompanying cesarean delivery. Obstet Gynecol (2009) 1.00

The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes. Am J Obstet Gynecol (2005) 1.00

Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery. Obstet Gynecol (2009) 1.00

Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. J Am Acad Child Adolesc Psychiatry (2008) 0.98

Metabolism of 17alpha-hydroxyprogesterone caproate by hepatic and placental microsomes of human and baboons. Biochem Pharmacol (2008) 0.98

Elevated vaginal pH and neutrophils are associated strongly with early spontaneous preterm birth. Am J Obstet Gynecol (2003) 0.97

The utility of menstrual cycle length as an indicator of cumulative hormonal exposure. J Clin Endocrinol Metab (2012) 0.97

The change in the rate of vaginal birth after caesarean section. Paediatr Perinat Epidemiol (2010) 0.96

Previous preterm cesarean delivery and risk of subsequent uterine rupture. Obstet Gynecol (2008) 0.96

The MFMU Cesarean Registry: impact of fetal size on trial of labor success for patients with previous cesarean for dystocia. Am J Obstet Gynecol (2006) 0.96

Tumor necrosis factor-alpha promoter gene polymorphism -308 and chorioamnionitis. Obstet Gynecol (2003) 0.95

Fish consumption, erythrocyte fatty acids, and preterm birth. Obstet Gynecol (2011) 0.95

Complications of anesthesia for cesarean delivery. Obstet Gynecol (2005) 0.95

Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). J Gen Intern Med (2012) 0.94

Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Am J Obstet Gynecol (2004) 0.93

Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes. Drug Metab Dispos (2010) 0.93

Timing of delivery and adverse outcomes in term singleton repeat cesarean deliveries. Obstet Gynecol (2013) 0.92

Midpregnancy genitourinary tract infection with Chlamydia trachomatis: association with subsequent preterm delivery in women with bacterial vaginosis and Trichomonas vaginalis. Am J Obstet Gynecol (2006) 0.92

Differences in inflammatory cytokine and Toll-like receptor genes and bacterial vaginosis in pregnancy. Am J Obstet Gynecol (2005) 0.92

Elective repeat cesarean delivery compared with spontaneous trial of labor after a prior cesarean delivery: a propensity score analysis. Am J Obstet Gynecol (2012) 0.92

Frequency of uterine contractions in asymptomatic pregnant women with or without a short cervix on transvaginal ultrasound scan. Am J Obstet Gynecol (2004) 0.91

Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. Obstet Gynecol (2006) 0.91

Evaluation of Macaca mulatta as a model for genotoxicity studies. Mutat Res (2008) 0.91